488 related articles for article (PubMed ID: 30565431)
1. Hybrid Nanomedicine Fabricated from Photosensitizer-Terminated Metal-Organic Framework Nanoparticles for Photodynamic Therapy and Hypoxia-Activated Cascade Chemotherapy.
He Z; Dai Y; Li X; Guo D; Liu Y; Huang X; Jiang J; Wang S; Zhu G; Zhang F; Lin L; Zhu JJ; Yu G; Chen X
Small; 2019 Jan; 15(4):e1804131. PubMed ID: 30565431
[TBL] [Abstract][Full Text] [Related]
2. Programmable therapeutic nanoscale covalent organic framework for photodynamic therapy and hypoxia-activated cascade chemotherapy.
He H; Du L; Xue H; Wu J; Shuai X
Acta Biomater; 2022 Sep; 149():297-306. PubMed ID: 35811069
[TBL] [Abstract][Full Text] [Related]
3. Supramolecular micelles as multifunctional theranostic agents for synergistic photodynamic therapy and hypoxia-activated chemotherapy.
Huang X; Chen T; Mu N; Lam HW; Sun C; Yue L; Cheng Q; Gao C; Yuan Z; Wang R
Acta Biomater; 2021 Sep; 131():483-492. PubMed ID: 34265471
[TBL] [Abstract][Full Text] [Related]
4. A hybrid metal-organic framework nanomedicine-mediated photodynamic therapy and hypoxia-activated cancer chemotherapy.
Jia Z; Gao Y; Ni J; Wu X; Mao Z; Sheng G; Zhu Y
J Colloid Interface Sci; 2023 Jan; 629(Pt B):379-390. PubMed ID: 36162395
[TBL] [Abstract][Full Text] [Related]
5. Theranostic Liposomes with Hypoxia-Activated Prodrug to Effectively Destruct Hypoxic Tumors Post-Photodynamic Therapy.
Feng L; Cheng L; Dong Z; Tao D; Barnhart TE; Cai W; Chen M; Liu Z
ACS Nano; 2017 Jan; 11(1):927-937. PubMed ID: 28027442
[TBL] [Abstract][Full Text] [Related]
6. ROS-Responsive Selenium-Containing Carriers for Coencapsulation of Photosensitizer and Hypoxia-Activated Prodrug and Their Cellular Behaviors.
Song F; Li S; Sun C; Ji Y; Zhang Y
Macromol Biosci; 2021 Dec; 21(12):e2100229. PubMed ID: 34390189
[TBL] [Abstract][Full Text] [Related]
7. Oxygen-Self-Supplying and HIF-1α-Inhibiting Core-Shell Nanosystem for Hypoxia-Resistant Photodynamic Therapy.
Liu P; Xie X; Shi X; Peng Y; Ding J; Zhou W
ACS Appl Mater Interfaces; 2019 Dec; 11(51):48261-48270. PubMed ID: 31763809
[TBL] [Abstract][Full Text] [Related]
8. Self-Delivered and Self-Monitored Chemo-Photodynamic Nanoparticles with Light-Triggered Synergistic Antitumor Therapies by Downregulation of HIF-1α and Depletion of GSH.
Zhang Z; Wang R; Huang X; Luo R; Xue J; Gao J; Liu W; Liu F; Feng F; Qu W
ACS Appl Mater Interfaces; 2020 Feb; 12(5):5680-5694. PubMed ID: 31944660
[TBL] [Abstract][Full Text] [Related]
9. Photochemically-driven highly efficient intracellular delivery and light/hypoxia programmable triggered cancer photo-chemotherapy.
Zhang W; Zhang C; Yang C; Wang X; Liu W; Yang M; Cao Y; Ran H
J Nanobiotechnology; 2023 Jan; 21(1):11. PubMed ID: 36631855
[TBL] [Abstract][Full Text] [Related]
10. Aggregation-Induced Emission Photosensitizer-Engineered Anticancer Nanomedicine for Synergistic Chemo/Chemodynamic/Photodynamic Therapy.
Yu B; Liu M; Jiang L; Xu C; Hu H; Huang T; Xu D; Wang N; Li Q; Tang BZ; Huang X; Zhang W
Adv Healthc Mater; 2024 Apr; 13(11):e2303643. PubMed ID: 38115727
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic Therapy Combined with Antihypoxic Signaling and CpG Adjuvant as an In Situ Tumor Vaccine Based on Metal-Organic Framework Nanoparticles to Boost Cancer Immunotherapy.
Cai Z; Xin F; Wei Z; Wu M; Lin X; Du X; Chen G; Zhang D; Zhang Z; Liu X; Yao C
Adv Healthc Mater; 2020 Jan; 9(1):e1900996. PubMed ID: 31746153
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic Therapy Based on Nanoscale Metal-Organic Frameworks: From Material Design to Cancer Nanotherapeutics.
Guan Q; Li YA; Li WY; Dong YB
Chem Asian J; 2018 Nov; 13(21):3122-3149. PubMed ID: 30183134
[TBL] [Abstract][Full Text] [Related]
13. Nanophotosensitizers toward advanced photodynamic therapy of Cancer.
Lim CK; Heo J; Shin S; Jeong K; Seo YH; Jang WD; Park CR; Park SY; Kim S; Kwon IC
Cancer Lett; 2013 Jul; 334(2):176-87. PubMed ID: 23017942
[TBL] [Abstract][Full Text] [Related]
14. ROS-sensitive biomimetic nanocarriers modulate tumor hypoxia for synergistic photodynamic chemotherapy.
Liu H; Jiang W; Wang Q; Hang L; Wang Y; Wang Y
Biomater Sci; 2019 Aug; 7(9):3706-3716. PubMed ID: 31187794
[TBL] [Abstract][Full Text] [Related]
15. Cancer-Selective Bioreductive Chemotherapy Mediated by Dual Hypoxia-Responsive Nanomedicine upon Photodynamic Therapy-Induced Hypoxia Aggravation.
Zhu R; He H; Liu Y; Cao D; Yan J; Duan S; Chen Y; Yin L
Biomacromolecules; 2019 Jul; 20(7):2649-2656. PubMed ID: 31125209
[TBL] [Abstract][Full Text] [Related]
16. Ferroptosis Promotes Photodynamic Therapy: Supramolecular Photosensitizer-Inducer Nanodrug for Enhanced Cancer Treatment.
Zhu T; Shi L; Yu C; Dong Y; Qiu F; Shen L; Qian Q; Zhou G; Zhu X
Theranostics; 2019; 9(11):3293-3307. PubMed ID: 31244955
[TBL] [Abstract][Full Text] [Related]
17. Covalent Organic Framework Nanocarriers of Singlet Oxygen for Oxygen-Independent Concurrent Photothermal/Photodynamic Therapy to Ablate Hypoxic Tumors.
Dutta D; Wang J; Li X; Zhou Q; Ge Z
Small; 2022 Sep; 18(37):e2202369. PubMed ID: 35971160
[TBL] [Abstract][Full Text] [Related]
18. Cascade-amplifying synergistic effects of chemo-photodynamic therapy using ROS-responsive polymeric nanocarriers.
Sun CY; Cao Z; Zhang XJ; Sun R; Yu CS; Yang X
Theranostics; 2018; 8(11):2939-2953. PubMed ID: 29896295
[TBL] [Abstract][Full Text] [Related]
19. Tandem activated photodynamic and chemotherapy: Using pH-Sensitive nanosystems to realize different tumour distributions of photosensitizer/prodrug for amplified combination therapy.
Ji Y; Lu F; Hu W; Zhao H; Tang Y; Li B; Hu X; Li X; Lu X; Fan Q; Huang W
Biomaterials; 2019 Oct; 219():119393. PubMed ID: 31382206
[TBL] [Abstract][Full Text] [Related]
20. Calcium phosphate-based organic-inorganic hybrid nanocarriers with pH-responsive on/off switch for photodynamic therapy.
Nomoto T; Fukushima S; Kumagai M; Miyazaki K; Inoue A; Mi P; Maeda Y; Toh K; Matsumoto Y; Morimoto Y; Kishimura A; Nishiyama N; Kataoka K
Biomater Sci; 2016 May; 4(5):826-38. PubMed ID: 26971562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
